Siemens gets FDA nod on EPI sequences

Article

Siemens Medical Systems of Iselin, NJ, has received Food and Drug Administration 510(k) clearancefor an upgrade package that brings faster echo-planar imagingrise times to its 1.5-tesla Magnetom Vision MRI scanner. The packagewill be available as a free

Siemens Medical Systems of Iselin, NJ, has received Food and Drug Administration 510(k) clearancefor an upgrade package that brings faster echo-planar imagingrise times to its 1.5-tesla Magnetom Vision MRI scanner. The packagewill be available as a free upgrade to Vision scanners in thefield. It improves EPI rise times to 600 microseconds, comparedto 1200 microseconds on Vision's previous echo-planar sequence,which began shipping in November, according to Michael Sweitzer,product manager for MRI.

Rise times are the speed at which a scanner's gradients risefrom zero to maximum amplitude, which in Vision's case is fromzero to 25 mtesla/meter. Faster rise times help avoid respiratoryand blood-flow artifacts and are expected to improve Vision'sutility in future applications such as diffusion-perfusion imagingand functional imaging. Siemens is working on a hardware upgradeto Vision that will bring rise times down to 300 microseconds,Sweitzer said.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.